Skip to main content
Caplight Logo









iBody Inc.

iBody Inc.

Private
NagoyaHealthcare & Life Scienceshttps://www.ibody.co.jp/

Last Round

Strategic

Jan 5, 2023

Est. Valuation

$8.08M

Total Funding Raised

$3.21M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

iBody Inc. is a biotechnology company that provides a monoclonal antibody discovery platform and contract research services for pharmaceutical and diagnostic applications.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

antibody discoverymonoclonal antibody generationcontract research organizationCROcustom antibody servicedifficult antibody targetstherapeutic antibody discoveryEcobody technologyhuman monoclonal antibodiesrabbit monoclonal antibodiessingle-cell antibody discoveryantibody out-licensingcell-free expressionpharma servicesdiagnostic development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

iBody Inc. Comparables

Compare iBody Inc. with similar companies based on industry and business-model similarity.

iBody Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Epsilon Molecular Engineering, Inc.
85%
MabGenesis株式会社
78%
Chiome Bioscience Inc.
74%

iBody Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicJan 5, 2023
VC RoundAug 3, 2020
SeedMay 16, 2018

Key People

Founding team and executive leadership

Yo Amakusa

CEO

Executive Team

iBody Inc. Investors

Notable investors and investment history

iBody Inc. investors
InvestorRounds
OKB CapitalVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 26, 2026

    Monthly visitors increased 80% MoM.

  • Mar 3, 2026

    Monthly visitors increased 37% MoM, reaching 2.1K.

iBody Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

iBody Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about iBody Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersNagoya
Employee Range7
Year Founded2018
Last FundingJan 5, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?